Gilead Stock Jumps After Its Weight-Loss Drug Emerges From Under The Radar
Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.
Source: investors.com
Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.
Amgen shares surged more than 14% in late trade Thursday after topping Q1 earnings estimates and providing a positive update on its injectable weigh-loss drug MariTide.
Corrected Transcript 02-May-2024 Organon & Co. Q1 2024 Earnings Call ...
Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.75. Bausch Health Companies Inc.